KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elevance Health (ELV) Dividends Paid - Common (2016 - 2025)

Elevance Health (ELV) has disclosed Dividends Paid - Common for 15 consecutive years, with $377.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Dividends Paid - Common rose 1.07% to $377.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.5 billion, a 1.39% increase, with the full-year FY2025 number at $1.5 billion, up 1.39% from a year prior.
  • Dividends Paid - Common was $377.0 million for Q4 2025 at Elevance Health, down from $381.0 million in the prior quarter.
  • In the past five years, Dividends Paid - Common ranged from a high of $386.0 million in Q1 2025 to a low of $273.0 million in Q4 2021.
  • A 5-year average of $340.0 million and a median of $350.0 million in 2023 define the central range for Dividends Paid - Common.
  • Peak YoY movement for Dividends Paid - Common: rose 15.97% in 2021, then rose 0.79% in 2025.
  • Elevance Health's Dividends Paid - Common stood at $273.0 million in 2021, then rose by 12.09% to $306.0 million in 2022, then increased by 13.07% to $346.0 million in 2023, then grew by 7.8% to $373.0 million in 2024, then grew by 1.07% to $377.0 million in 2025.
  • Per Business Quant, the three most recent readings for ELV's Dividends Paid - Common are $377.0 million (Q4 2025), $381.0 million (Q3 2025), and $385.0 million (Q2 2025).